Feature 3DS Telo-HL test aims to personalize cancer treatment By Len Zehrs 3D Signatures (OTCQB:TDSGF; TSXV:DXD; FSE:3D0) has reported positive results from a preliminary analysis of trial data for Telo-HL, its test for Hodgkin’s lymphoma (HL) that is designed to personalize... February 20, 2018